On Monday August 21, 2023, National Fentanyl Awareness Day, Arizona's Governor Katie Hobbs and Senator Kyrsten Sinema made statements acknowledging the national opioid crisis and highlighting state and federal initiatives to curb overdose and deaths.
As Sen. Sinema notes in her press release, in Arizona more than five people die each...Arizona News
This week, Governor Katie Hobbs vetoed a number of Republican-supported bills, including measures that would redefine the beginning of life under the Arizona Constitution. Also, a newly revised striker bill would limit public health emergencies to seven days.
On Monday, Gov. Hobbs vetoed four bills including HB 2427, which would add...
The case count in Arizona shows no sign of abating as Arizona recorded almost 25,000 new cases of COVID-19 on January 15, setting a record. Hospitals and healthcare advocacy groups warn that the overburdened healthcare system is strapped for staff and resources as hospitalizations continue. On Wednesday, January 19, the state reported...
On Wednesday, October 5, there were 2,041 new cases of COVID-19 in Arizona, with 39 new deaths. Arizona’s COVID-19 death total of 20,000 amid the state’s third virus surge, is a heartbreaking reminder of COVID's lethality. Under 60% of Arizonans have received one shot of the COVID-19 vaccine. Only 7% of hospital intensive care unit...
Founder of opioid maker Insys Therapeutics John Kapoor, 76, was sentenced to 5 1/2 years in prison. The former billionaire, along with other executives, were convicted of organizing a national bribery scheme that ultimately was found to have fueled the opioid epidemic.
Kapoor was given his 66 month sentence for the role he played...Arizona News
The manufacturer of a potent fentanyl spray, Subsys, appears to be shutting down operations after filing for bankruptcy last summer and years of litigation.
Insys Therapeutics agreed to vacate its Chandler headquarters by Dec. 31, 2019 and according to bankruptcy filings, any property belonging to debtors that remain after Dec. 31...Arizona News
Chandler-based drug manufacturer Insys Therapeutics, infamous for the questionable marketing practices of its highly-addictive opioid fentanyl spray Subsys, announced plans to sell off assets to Wyoming-based BTcP Pharma and London-based Hikma Pharmaceuticals in a series of U.S. Securities and Exchange Commission filings.
After...Arizona News
Last week, a federal jury found Arizona billionaire John Kapoor and four other executives of Insys Therapeutics guilty of conspiring to bribe doctors to inflate sales for the pain drug Subsys, an opioid approved to treat breakthrough cancer pain that's 100 times stronger than morphine.
Kapoor, the founder and former CEO of Insys...Arizona News
Insys Therapeutics manufactures Subsys, a highly addictive fentanyl spray which is meant only for cancer patients with severe pain.
Jerrold Rosenberg, a Rhode Island doctor, pleaded guilty in U.S. District Court in Providence to one count each of health care fraud and kickbacks conspiracy.
The doctor admitted on Wednesday that he...
The Chandler-based firm manufactures an opioid, Subsys, that contains fentanyl.
Insys began selling Subsys in March 2012 as a sublingual fentanyl spray to manage breakthrough pain in cancer patients through its 250-personal sales force. Last November, Insys was named the fastest growing pharmaceutical company in Arizona, according...
Based in Chandler, the company's former CEO Michael Babich, its regional sales directors and four more former employees allegedly paid pain doctors to ramp up their prescribing habits for Subsys, a spray form of Fentanyl, which is 50 times stronger than heroin and 100 times stronger than morphine.
Federal prosecutors arrested several...
